Review of The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells

Pre-publication Review of

The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells

Reviewed On December 02, 2022

Verified

Submitted to

Reviewed by

Actions

Reviewed on December 02, 2022

Source

References

Laura, U., Stefan, U. M., Helene, S., Hieu-Hoa, D., Theresa, N., Christof, R., Julia, V., Susanne, S., M., W. S., Emanuela, K., X., W. C., W., K. P., Michela, L., Lisa, P., Richard, G., G., H. C., Fritz, A., Jutta, H. 2023. The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. Cancers.